Sales Desk – US   877.701.2883
Sales Desk – UK   +44 (0)20.8819.6490
US INVESTORS
Non-US INVESTORS
Sales Desk – US   877.701.2883
Sales Desk – UK   +44 (0)20.8819.6490
US INVESTORS
Non-US INVESTORS

Bloomberg: Tony Scherrer talks about Pharma Earnings and Cancer Drugs

Cancer’s Six-Figure Blockbuster Hopefuls Aid Drugmaker Sales

By Cynthia Koons

For more information go to www.bloomberg.com.

 

The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results. The securities identified and described in this article do not represent all of the securities purchased or recommended for our clients. It should not be assumed that investing in these securities was or will be profitable. A list of all recommendations made by Smead Capital Management with in the past twelve month period is available upon request.

We Advise Investors

Sign up to get our advice sent straight to your inbox.

Sign Up

Recent Missives

BNN Bloomberg: Cole Smead, CFA on Pipestone Takeover

September 27, 2023

    Takeover by Adam Waterous is a sweet deal for Pipestone: Cole Smead   For more information go to www.bnnbloomberg.ca. Stocks mentioned: PIPE The information contained in this article represents … BNN Bloomberg:...

⟶ Keep Reading

The Canadian Press: Cole Smead, CFA on Pipestone Energy Merger

September 27, 2023

Pipestone shareholders approve merger with Strathcona Resources By Amanda Stephenson For more information go to www.thecanadianpressnews.ca. Stocks mentioned: PIPE The information contained in this article represents SCM’s opinions, and should … The Canadian...

⟶ Keep Reading

Everything in Moderation

September 26, 2023

[...] We have taken the view that our eight criteria for stock selection will guide us to invest in great companies at very favorable valuations allowing us to be able to compound our...

⟶ Keep Reading

Barron’s: Bill Smead on Market Imbalance in Oil Stocks

September 20, 2023

Oil Is Soaring. Why the Stocks Have Stalled—and How You Can Take Advantage. By Avi Salzman For more information go to www.barrons.com. Stocks mentioned: COP, OXY The information contained in … Barron’s: Bill...

⟶ Keep Reading

CNBC The Exchange: Cole Smead, CFA on Opportunities in Individual Equities

September 19, 2023

Indexes are struggling but opportunity exists in individual equities, says Cole Smead For more information go to www.cnbc.com. Stocks mentioned: LEN The information contained in this tv appearance represents SCM’s … CNBC The...

⟶ Keep Reading

Oil Stock Disconnect

September 19, 2023

[...] Fortunately for us, push eventually comes to shove. Since there is no end in sight in the demand for fossil fuels and there is only criticism for those who are poking holes...

⟶ Keep Reading

We Advise Investors

Sign up to get our advice sent straight to your inbox.

Sign Up

US INVESTORS

Individual Investors

  • CALL 877.807.4122

OR

We'll call you

Financial Advisors, Family Offices,
and Institutional Investors

  • CALL 877.701.2883

OR

We'll call you

NON-US INVESTORS

Individual Investors

  • CALL +352-46-40-10-600

OR

We'll call you

Financial Advisors, Family Offices,
and Institutional Investors

  • CALL +44 (0)20-8819-6490

OR

We'll call you

© Copyright 2023. Smead Capital Management. All rights reserved.

© Copyright 2022. Smead Capital Management.
All rights reserved.

Scroll to Top